Raphael Pharmaceutical RAPH
OTC RAPH
$1.40 +0.00 (+0.00%)
At close: Sep 28, 2026 · 4:00 PM EDT

Raphael Pharmaceutical Inc. (RAPH) Profit After Tax (2020 - 2026)

Updated

Raphael Pharmaceutical's Profit After Tax came in at -$199,000 for Q2 2026, compared with -$315,000 a year earlier.

Analysis

Raphael Pharmaceutical Inc. (RAPH) Profit After Tax (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Raphael Pharmaceutical reported Profit After Tax of -$1.23 million; for FY2025, it came in at -$1.25 million.

  • Going back by year, Profit After Tax was -$1.51 million in FY2024, -$1.27 million in FY2023, -$3.32 million in FY2022 and -$1.63 million in FY2021.
  • The Q2 2026 figure represents the highest quarterly Profit After Tax since Q4 2023.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -199,000.00
Jun 30, 2025 -315,000.00
Dec 31, 2024 -394,000.00
Sep 30, 2024 -319,000.00
Jun 30, 2024 -249,000.00
Mar 31, 2024 -547,000.00
Dec 31, 2023 134,000.00
Sep 30, 2023 -729,000.00
Jun 30, 2023 -419,000.00
Mar 31, 2023 -258,000.00
Dec 31, 2022 -1.10 Mn
Sep 30, 2022 -1.43 Mn
Jun 30, 2022 -612,000.00
Mar 31, 2022 -175,000.00
Dec 31, 2021 -574,000.00
Sep 30, 2021 -418,000.00
Jun 30, 2021 -385,000.00
Mar 31, 2021 -252,000.00
Dec 31, 2020 -227,000.00
API Access

Raphael Pharmaceutical Inc. Profit After Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=profit-after-tax&ticker=RAPH&period=max&api_key=YOUR_API_KEY